Probiotic Supplement
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Immunosuppressant Associated Diarrhea
Conditions
Immunosuppressant Associated Diarrhea
Trial Timeline
Jul 1, 2006 → Dec 1, 2009
NCT ID
NCT00364650About Probiotic Supplement
Probiotic Supplement is a pre-clinical stage product being developed by Roche for Immunosuppressant Associated Diarrhea. The current trial status is completed. This product is registered under clinical trial identifier NCT00364650. Target conditions include Immunosuppressant Associated Diarrhea.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00364650 | Pre-clinical | Completed |